Biography
Edward Horn, PharmD, joined the Department of Pharmacy and Therapeutics at the School of Pharmacy in July 2018 and holds the title of Associate Professor. He also serves as a clinical pharmacist in heart transplantation and mechanical circulatory support with the University of Pittsburgh Medical Center Heart and Vascular Institute. In 2022, he was named as the Associate Director of the Cardiac Transplant Program at the UPMC Heart and Vascular Institute. He received his Doctor of Pharmacy degree from the University of Pittsburgh in 2000, with subsequent post-graduate training. Horn completed his PGY-1 Pharmacy Practice Residency at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania. Upon completion, he returned to the University of Pittsburgh for his PGY-2 Specialty Residency in Critical Care Pharmacy Practice.
From 2002-2007, Horn was a clinical pharmacy specialist in Trauma/Surgical Critical Care at the Johns Hopkins Hospital in Baltimore, Maryland. During that time, he aided in the care of the critically ill and was active in both student and resident precepting, as well as clinical research. He then joined the pharmacy department at Allegheny General Hospital in Pittsburgh in 2007 as a clinical pharmacy specialist in cardiothoracic surgery with key roles in the in the cardiothoracic surgery ICU, heart transplant, and mechanical circulatory support programs there. He also served as the critical care pharmacy residency program director there from 2012 to 2018.
Horn's current clinical practice sites include the heart transplant clinic as well as the heart transplant/mechanical support service at UPMC. His clinical research interests surround improving the long-term care of both heart transplant recipients and patients with durable mechanical support devices, including immunosuppression management, management of antibody mediated rejections and highly sensitized patients, and anticoagulant/antiplatelet monitoring in mechanical circulatory support.
Honors / Awards
- Phi Lambda Sigma, Honorary Member 2021
- APPE Preceptor of the Year, University of Pittsburgh School of Pharmacy 2021-2022
Presentations
- Daratumumab for refractory donor specific antibodies in thoracic transplantation.
- Sacha L, Moore CA, Iasella C, Keebler ME, Zeevi A, Xu Q, Kaczorowski DJ, Horn ET.
- Presented at the American Transplant Congress 2024 Annual Meeting
- June 1-5, 2024
- Philadelphia PA
- Daratumumab for refractory AMR rejection after adolescent heart transplant.
- Skowronski J, Horn ET, Xu Q, Keebler ME
- Presented at the International Society for Heart and Lung Transplant 44th Annual Meeting
- April 10-13, 2024
- Prague, Czechia
- Advanced therapy eligibility in patients with axillary Impella for cardiogenic shock
- Sicke M, Modi S, Schiemer M, Barrington W, Klass W, Ziegler K, Toma C, Horn E, Kaczorowski D, Ramanan R, Garvia V, Hickey GW.
- Presented at CRF Technology and Heart Failure Therapeutics
- March 4-6, 2024
- Boston, MA
- A brave new world: utilization of assisted reproductive technology after heart transplantation
- Skowronski J, Hickey GW, Horn E, Rios J, Mathier MA, Levene J, Berlacher KL
- Presented at the American College of Cardiology Annual Meeting (ACC.24)
- Atlanta, GA
- April 6-8, 2024
- Bridging with BiVad: overcoming high allosensitization in peripartum cardiomyopathy
- Skowronski J, Horn E, Keebler M, Ramana R, Hickey GW.
- Presented at the American College of Cardiology Annual Meeting (ACC.24)
- Atlanta, GA
- April 6-8, 2024
- Mechanical circulatory support prior to combined heart-kidney transplant – a long but worthy fight to fight
- Jaramillo-Restreop V, Hess N, Horn E, Kaczorowski DJ, Hickey GW
- Presented at the American College of Cardiology Annual Meeting (ACC.24)
- Atlanta, GA
- April 6-8, 2024
- Treatment of Impella 5.5 purge dysfunction with tissue plasminogen activator prevents subsequent pump exchanges.
- Sicke M, Klass W, Rivosecchi R, Bashline M, Fowler J, Horn E, Hess N, Kaczorowski D, Hickey W.
- Presented at the American Society for Artificial Internal Organs Annual Meeting
- San Francisco, CA
- June 14-17, 2023
- Significant reduction in donor specific antibodies in heart transplant patients treated with proteasome inhibitors for antibody mediated rejection.
- Horn ET¸ Xu Q, Tushak Z, Dibridge JN, Huston JH, Hickey GW, Kaczorowski DJ, Keebler ME, Zeevi A.
- Presented at the International Society for Heart and Lung Transplantation Annual Meeting
- Boston, MA
- April 26-29, 2022
- A single center experience of concomitant administration of sofosbuvir/velpatasvir and amiodarone after heart or lung transplantation
- Rivosecchi RM, Silveira FP, Sacha LM, Horn ET, Keebler ME, Sanchez PG.
- Presented at the International Society for Heart and Lung Transplantation Annual Meeting
- Boston, MA
- April 26-29, 2022
- Basiliximab versus Methylprednisolone for induction in adult heart transplantation
- Rudzik K, Rivosecchi RM, Edwards JN, Palmer BA, Hickey GW, Huston JH, Keebler ME, Kaczorowski DJ, Horn ET.
- Presented at the International Society for Heart and Lung Transplantation Annual Meeting
- Boston, MA
- April 26-29, 2022
- Treatment of antibody mediated rejection complicated but cardiogenic shock with a temporary left ventricular assist device as a bridge to recovery.
- Fabrizio C, Horn ET, Stokes N, Rhinehart Z, Hickey GW, Keebler ME.
- Presented at the International Society for Heart and Lung Transplantation Annual Meeting (Virtual)
- April 24-28, 2021
- Optimizing antibiotic therapy of ventricular assist device patients with driveline infections and associated bacteremias through the development of an antibiogram
- Liang A, Hopwood-Brophy A, Horn ET.
- Presented at The American Society of Health System Pharmacy Midyear Clinical Meeting
- Virtual Meeting
- December 6-10, 2020
